The Economic Times

Weight-loss drug boom: Will cheaper Ozempic generics shake up Indias fitness and nutrition industry?

The rise of GLP-1 weight-loss drugs such as Ozempic is posing a challenge to the fitness industry, with cheaper generic versions expected to enter India soon. While some fear this could lead to a decline in gym memberships, others see it as an opportunity to offer specialised training and integrated wellness programmes to support people using these medications.